Ozanimod - Celgene Corporation
At a glance
- Drug Originator The Scripps Research Institute
- Drug Licenced by Celgene Corporation
- Drug Class Amines; Anti-inflammatories; Antivirals; Benzene derivatives; Indenes; Nitriles; Oxadiazoles; Small molecules
- Mechanism of Action Sphingosine 1 phosphate receptor modulators
- USA Patent Applicants CELGENE INTL
- USA Patents 16
- NDAs 1
- International Patents 160
- Patent Applications 8
Table of Contents

Disclaimer